OptiBiotix Health PLC (AIM:OPTI) (OptiBiotix Health PLC (AIM:OPTI)) Stephen O’Hara talks to Proactive London about the year ahead, with plans to generate its first products to market to help provide the base for the next generation of pre’ and probiotics.
He tells investors, three deals signed at the end of last year have the potential to positively shape 2022 and believes new product launches in 2022, the extension of territories with existing partners, new product platforms, and the commercial realisation of our development pipeline, will allow them to look forward with confidence to further commercial progress of the Group in the current year and beyond.